ABBV
AbbVie Inc
264.50$
+0.2%
vs. previous close
Closing price · As of: Sep 21, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +112.3% | -6.6% | +41.5% | +34.8% | -0.8% | +32.0% | +29.5% | +9.5% | -8.4% | -17.7% | +1.2% | |
| – | +6.4% | +42.2% | +26.2% | +17.6% | +14.3% | +220.8% | +31.7% | -0.6% | +2.7% | -3.6% | -2.9% | |
| – | +17.0% | +25.2% | +3.4% | +15.3% | +2.1% | +75.1% | -8.1% | -3.0% | +11.3% | +22.0% | +4.8% | |
| – | -40.9% | +51.1% | +19.6% | +251.6% | -28.8% | +34.4% | -36.9% | -34.3% | – | – | – | |
| – | – | -435.1% | – | -12,611.1% | – | – | -1,347.2% | – | – | -198.9% | – | |
| – | -13.1% | -10.0% | +10.4% | +20.6% | -13.5% | +44.6% | -1.4% | -11.7% | +11.8% | +25.4% | +24.6% | |
| – | +1,297.0% | -53.0% | -95.5% | +267.2% | – | -6,401.5% | -93.8% | -73.4% | +222.5% | +936.3% | -68.1% | |
| – | +23.8% | +12.8% | +10.5% | +35.9% | +14.1% | +21.2% | +20.0% | +8.4% | +4.9% | +4.6% | +5.7% | |
| – | +1,040.8% | -20.5% | -76.6% | +752.1% | -94.8% | +55.5% | -4.5% | +59.2% | +32.6% | -13.4% | -42.6% | |
| – | +136,908.3% | -66.4% | -100.1% | – | +709.8% | -110.5% | +211.3% | +47.8% | -66.6% | – | -104.1% | |
| – | – | -168.3% | +40.3% | +161.2% | – | -161.5% | +65.5% | +30.3% | -30.6% | -69.7% | +144.2% | |
| – | – | -6,568.6% | – | -147.9% | – | -196.4% | – | -142.0% | – | -301.8% | – | |
| – | +138.4% | -6.3% | +43.7% | +35.6% | -0.1% | +31.5% | +31.0% | +10.3% | -9.0% | -19.2% | -0.1% |
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.